CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $347,711,405
- in 75 filings, $346.9M under 10b5-1 plans
Net −$347,711,405. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-03 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −954 | $485.12 | $463K | 46,269 |
| 2026-09-03 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −598 | $486.47 | $291K | 45,671 |
| 2026-09-03 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −169 | $487.36 | $82K | 45,502 |
| 2026-09-03 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −10 | $488.32 | $5K | 45,492 |
| 2026-09-03 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −320 | $490.89 | $157K | 45,172 |
| 2026-09-03 | MAHON PAUL A EVP & GENERAL COUNSEL | Option exercise · Stock Option 10b5-1 | −8,300 | 55,840 | ||
| 2026-09-02 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $135.42 | $1.3M | 333,943 |
| 2026-09-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −120 | $477.70 | $57K | 333,823 |
| 2026-09-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −160 | $478.85 | $77K | 333,663 |
| 2026-09-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −160 | $479.89 | $77K | 333,503 |
| 2026-09-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −80 | $482.61 | $39K | 333,423 |
| 2026-09-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −120 | $485.12 | $58K | 333,303 |
| 2026-09-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −160 | $486.32 | $78K | 333,143 |
| 2026-09-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −240 | $489.06 | $117K | 332,903 |
| 2026-09-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −560 | $490.19 | $275K | 332,343 |
| 2026-09-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,833 | $491.38 | $901K | 330,510 |
| 2026-09-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,067 | $492.25 | $1.0M | 328,443 |
| 2026-09-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −520 | $493.59 | $257K | 327,923 |
| 2026-09-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −520 | $494.33 | $257K | 327,403 |
| 2026-09-02 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −423 | $495.95 | $210K | 326,980 |
Page 42 of 121 · 2,404 trades